II. Global Audience!
Are euroPLX Meetings just for European companies?
No. It is international in scope and to date more than 1,200 companies from 70 countries have attended, from all over Europe, Africa, the Americas, Asia, Australia, and Oceania. The business between European and non-European companies is even given particular emphasis.
How come mainstream partnering events have a larger audience than euroPLX Meetings?
Because mainstream partnering events have no people focus: government people, consultants, head-hunters, investment bankers, press and other non-core audience are allowed to attend, taking away time for serious collaboration business.
euroPLX Meetings are strictly limited to executives in charge of business development and licensing. Consultants/brokers with clear and proven mandates or investments in own products or developments are also admitted. When the limit of about 120-140 pharma or biopharma companies is reached, euroPLX accepts (few) additional companies only when they are a good match with those already registered.
What if a person registers that does not belong to the core group of business development or licensing executives?
euroPLX will not accept the registration. An exception is made for license brokers or consultants if (a) they can prove that they have an ongoing mandate by a pharma client to in-license or out-license a product or technology, or (b) they have invested in own product rights which they seek to sell.
What if a delegate of a company other than pharma or biopharma registers?
If we receive an registration of a company that is unknown to us, we will verify the nature of its business. If we cannot find evidence that the company is a pharmaceutical or biopharmaceutical developer, manufacturer, wholesaler, distributor, intermediates supplier, or technology provider, euroPLX will regret not to accept the registration.
Delegates' Comments
Dr. Norbert Rau
Paul Phull
Anke Rau and Dr. Norbert Rau
Sebastien Sanial and Malgorzata Derewianka
Dr. Peter Komnick and Dr. Silke Behne
Rich DiCicco
Kees Trommelen
Dragan Lutz and Mario Vlasic
Dr. Satyendra Kumar
Peter van Hoogstraten and Paul C. Borghouts
Ronald Kriek and Wouter Hanegraaf
Simona Aganovic and Guy Clark
Vilas Nagare and Sundeep V. Bambolkar
Jinang Parekh and Vijay Agarwal
Dr. Hubert Ridolphi and Dr. Gerrit Hagens
pharmaceutical business…"
Gilbert Adatte
Ramon Brusco
Patrick Tichy
Daniel Jones
Nuray Acar and Mutlu Topal
Ruud Koolen
Ana Paula Branco and José Roberto Pereira
David Zubeldía
Gustavo Samojeden and Hernán Bouzada
Dietmar Jannaschk and Gemma Mogas
Marc Alvarez
Sylvie Fondanayche
Holger and Kai Schleenhain
Reynhardt Van As
Santiago, Mar, and Josémaria Calzada
Agnes Olszanowski and Dr. Marian Takac
Wendell Clayton
Rich DiCicco
Andreas Wagner & Michel Blanc
Wolfgang Bäurle
Patsy Carney
Roland Brown
Elzbieta Weston & Jacek Plucienniczak